immuno-oncology

layoffs job cuts fired exit restructuring layoff reduction
Marketing

Coherus loses commercial chief amid exit from biosimilar space

As the biotech completes its pivot away from biosimilars, Reider has resigned as chief commercial officer to pursue other opportunities.
Nick Paul Taylor Apr 23, 2025 11:19am
BMS

BMS follows Roche, AstraZeneca into first-line liver cancer

Apr 11, 2025 1:53pm
tuberculosis vaccine

ImmunityBio, SII win FDA nod to help combat BCG shortage

Feb 19, 2025 9:01am
Focus magnify target strategy

Agenus to offer CDMO services, lay off staffers in latest reorg

Dec 5, 2024 7:51am
merger virtual handshake

Coherus sells Neulasta biosimilar to Intas for up to $558M

Dec 3, 2024 4:16pm
question unanswered wonder ask

Incyte touts 2 trial wins for PD-1 drug Zynyz amid I-O retreat

Jul 30, 2024 11:27am